In the Indian state of Maharashtra, the Food and Drug Administration hasasked the pharmaceutical industry to help it track down manufacturers of counterfeit drugs. Noting that the agency is understaffed, the state's Joint FDA Commissioner, Mr R W Gudal, said it has asked drugmakers to cooperate in this area by utilizing their "extensive field staff," reports The Times Of India.
The request was welcomed by the Indian Drug Manufacturers' Association's president, Mr N Israni, who said the only solution to this "immense" problem was closer cooperation between the industry, the law and the enforcement mechanisms. Companies are "more than willing to collaborate with the FDA, both in their own interest as well as for the benefit of consumers," he said. However, Ajit Dangi, Director General of the Organisation of Pharmaceutical Producers of India, said the only way to curb the trade in fake drugs was for consumers to be more careful. "They should buy only prescribed drugs and demand bills from the chemists," he said.
The World Health Organization has identified India as one of the world's worst offenders for counterfeit drug manufacture, with about 20% of drugs made in the country estimated to be fake, according to the report.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze